Table 1 Clinical and histopathological characteristics of ILC and IDC patients

Age (n = 105; 32, 73)^a

52 ± 9.46

53.28 ± 9.52

51.44 ± 9.44

0.529

Tumor size (n = 104; 31, 73)^a

2.25 ± 1.56

2.64 ± 1.13

2.08 ± 1.69

0.002

Tumor Grade (n = 105; 32, 73)^a

0.709

 Grade 1

35 (33.3)

9 (28.1)

26 (35.6)

 Grade 2

53 (50.5)

18 (56.3)

35 (48.0)

 Grade 3

17 (16.2)

5 (15.6)

12 (16.4)

ER (n = 104; 31, 73)^a

0.031

 Negative

20 (19.2)

2 (6.5)

18 (24.7)

 Positive

84 (80.8)

29 (93.6)

55 (75.3)

PR (n = 103; 31, 72)^a

0.023

 Negative

33 (32.0)

5 (16.1)

28 (38.9)

 Positive

70 (68.0)

26 (83.9)

44 (61.1)

HER2 (n = 91; 30, 61)^a

0.039

 Negative

74 (81.3)

28 (93.3)

46 (75.4)

 Positive

17 (18.7)

2 (6.7)

15 (24.6)

EGRF (n = 98; 27, 71)^a

0.221

 Negative

82 (83.7)

25 (92.6)

57 (80.3)

 Positive

16 (16.3)

2 (7.4)

14 (19.7)

Ki-67 (n = 99; 27, 72)^a

0.003

 Negative

57 (57.6)

22 (81.5)

35 (48.6)

 Positive

42 (42.4)

5 (18.5)

37 (51.4)